TITLE

FDA APPROVES TARO'S ANDA FOR DIFLORASONE DIACETATE CREAM

PUB. DATE
June 2000
SOURCE
Worldwide Biotech;Jun2000, Vol. 12 Issue 6, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that Taro Pharmaceuticals Inc. has received notification from the United States Food and Drug Administration approving its Abbreviated New Drug Application for Diflorasone Diacetate Cream.
ACCESSION #
3229259

 

Related Articles

  • FDA approves ANDA for Taro's Ketoconazole.  // Drug Store News;7/19/99, Vol. 21 Issue 11, pCP6 

    Reports the approval of the United States Food and Drug Administration for Taro Pharmaceutical Industries' to market the anti-fungal drug Ketoconazole Tablets USP, 200 milligrams. Brief information on the drug.

  • Taro's ANDA for Clobetasol Propionate Gel, 0.05% approved.  // Drug Store News;7/19/99, Vol. 21 Issue 11, pCP29 

    Deals with the approval of the United States Food and Drug Administration on the marketing of Clobetasol Propionate Gel, a topical corticosteroid for dermatologic problems from Taro Pharmaceuticals. Classification of the drug.

  • Taro gains approval for Phenytoin oral suspension ANDA.  // PharmaWatch: CNS;April 2004, Vol. 3 Issue 4, p18 

    Reports on the grant of approval for Phenytoin Oral Suspension by the U.S. Food and Drug Administration to Taro Pharmaceutical Industries Ltd. Use of the drug to target epilepsy; Authorization for the pediatric use of the drug; Other drug application of the company.

  • Taro Resolves FDA Warning Letter Regarding Canadian Manufacturing Facility.  // Biomedical Market Newsletter;5/7/2011, p6 

    The article reports on the issues concerning the Canadian manufacturing facility of Taro Pharmaceutical Industries Ltd. which have been resolved with the U.S. Food and Drug Administration (FDA). It states that the FDA confirmed that the site has an acceptable regulatory status after a...

  • Taro Receives FDA Approval for Imiquimod Cream, 5%.  // Biomedical Market Newsletter;5/7/2011, p538 

    The article reports on the approval granted by the U.S. Food and Drug Administration for Taro Pharmaceutical Industries Ltd.'s Abbreviated New Drug Application (ANDA) for Imiquimod Cream.

  • REPORTERS Notebook.  // Drug Store News;4/23/2007, Vol. 29 Issue 6, p35 

    The article reports developments in the pharmaceutical industry in the U.S. Janssen's Risperdal was approved by the Food and Drug Administration (FDA) for children, giving it six months' pediatric marketing exclusivity. Ranitidine syrup oral solution USP from Actavis and Taro received approval...

  • PHARMA & FINE CHEMICALS: MARKET BRIEFS.  // Chemical Market Reporter;05/01/2000, Vol. 257 Issue 18, p12 

    Presents news briefs from the pharmaceutical and fine chemicals industries in the United States as of May 1, 2000. Approval received by Taro Pharmaceutical Industries Ltd. from the Food and Drug Administration (FDA) for diflorasone diacetate cream USP; FDA approval received by Aventis...

  • Taro Provides Results for Quarter Ended June 2012.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article provides information on the unaudited financial results for the three month period ended on June 30, 2012 of Taro Pharmaceutical Industries Ltd. It informs about the major shareholder of the company including Sun Pharmaceutical Industries Ltd. It also informs about net sales of 159.2...

  • BREAKING NEWS.  // Pharmaceutical Technology;Jul2007, Vol. 31 Issue 7, p22 

    The article provides update related to the pharmaceutical industry in the U.S. Copernicus Therapeutics Inc. found that the methods used to produce deoxyribonucleic acid (DNA) can also be applied to small interfering ribonucleic acid (siRNA). Sun Pharmaceutical Industries Ltd. and its...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics